Guilhem de Vregille is a partner at XAnge, a leading European venture capital firm managing €450 million and a portfolio of 55 startups. Guilhem serves as an investor and board member for various companies including Qubit Pharmaceuticals, RIOTS, TreeFrog Therapeutics, Aerospacelab, Wandercraft, Elum Energy, POLLEN Metrology, and Mdoloris Medical Systems, contributing expertise across sectors such as biotechnology, deep tech, energy, and healthcare. Guilhem's educational background includes coursework at emlyon business school and a degree from ECAM LaSalle.
Sign up to view 0 direct reports
Get started
This person is not in any teams